Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports completion of arsenic trioxide in patients with advanced hematologic cancers, including leukemia and lymphoma, with pote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED